HIGHLIGHTS
- who: Fangcheng Shen and collaborators from the Jiangsu University, China have published the paper: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: A retrospective analysis, in the Journal: (JOURNAL) of 17/02/2023
- future: In their study the study identified SNX20 as a novel potential prognostic biomarker and described the functional role of SNX20 in the progression of LGG providing a new potential diagnostic and therapeutic biomarker for LGG in the future .
SUMMARY
The efficacy and adverse effects of anlotinib in the treatment of high . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.